Skip to Content

4896 SB (Requip 4 mg)

Generic Name: ropinirole

Pill with imprint 4896 SB is Brown, Five-sided and has been identified as Requip 4 mg. It is supplied by GlaxoSmithKline.

Requip is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4896 SB

Requip 4 mg 4896 SB
Requip 4 mg 4896 SB Front
Requip 4 mg 4896 SB Back
Requip 4 mg 4896 SB
Requip 4 mg 4896 SB

Requip

Generic Name
ropinirole
Imprint
4896 SB
Strength
4 mg
Color
Brown
Size
8.00 mm
Shape
Five-sided
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)
00007-4896
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, hypromellose 2910 (6 mPa.s), polyethylene glycol 400, titanium dioxide, FD&C Yellow No. 6, FD&C Blue No. 2, indigotindisulfonate sodium, aluminum oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.